EXA-70862-69334 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-23
Dose 1 — Pfizer-BioNTech
2022-06-24
Registered in v-safe
2022-06-24
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Irritability/crying, Loss of appetite

Under 3 check-in
2022-06-25
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-26
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-27
Survey response — days 1–6 daily, dose 1, under 3
MedDRA: Unevaluable event — Feeling: Good · Loss of appetite

Free text: Teething

MedDRA releases: 2024-11 · check-in free text available
2022-06-28
Survey response — days 1–6 daily, dose 1, under 3
MedDRA: Teething — Feeling: Good · Loss of appetite

Free text: Teething

MedDRA releases: 2024-11 · check-in free text available
2022-06-29
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-30
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-23	Pfizer-BioNTech	No

Free text

Release 12 (Under 3) — days 1–6 daily, dose 1, under 3

2022-06-27

Systemic reaction (other): Teething

2022-06-28

Systemic reaction (other): Teething

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Teething	·	·	✓
SRO	Unevaluable event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release